230 related articles for article (PubMed ID: 31089138)
1. miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8
Ji Y; Fioravanti J; Zhu W; Wang H; Wu T; Hu J; Lacey NE; Gautam S; Le Gall JB; Yang X; Hocker JD; Escobar TM; He S; Dell'Orso S; Hawk NV; Kapoor V; Telford WG; Di Croce L; Muljo SA; Zhang Y; Sartorelli V; Gattinoni L
Nat Commun; 2019 May; 10(1):2157. PubMed ID: 31089138
[TBL] [Abstract][Full Text] [Related]
2. Polycomb Repressive Complex 2-Mediated Chromatin Repression Guides Effector CD8
Gray SM; Amezquita RA; Guan T; Kleinstein SH; Kaech SM
Immunity; 2017 Apr; 46(4):596-608. PubMed ID: 28410989
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1.
Renrick AN; Thounaojam MC; de Aquino MTP; Chaudhuri E; Pandhare J; Dash C; Shanker A
Front Immunol; 2021; 12():607044. PubMed ID: 33717088
[TBL] [Abstract][Full Text] [Related]
4. Targeting
Le PT; Ha N; Tran NK; Newman AG; Esselen KM; Dalrymple JL; Schmelz EM; Bhandoola A; Xue HH; Singh PB; Thai TH
Front Immunol; 2021; 12():738958. PubMed ID: 34721405
[TBL] [Abstract][Full Text] [Related]
5. miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines.
Ji Y; Wrzesinski C; Yu Z; Hu J; Gautam S; Hawk NV; Telford WG; Palmer DC; Franco Z; Sukumar M; Roychoudhuri R; Clever D; Klebanoff CA; Surh CD; Waldmann TA; Restifo NP; Gattinoni L
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):476-81. PubMed ID: 25548153
[TBL] [Abstract][Full Text] [Related]
6. PHF19 mediated regulation of proliferation and invasiveness in prostate cancer cells.
Jain P; Ballare C; Blanco E; Vizan P; Di Croce L
Elife; 2020 Mar; 9():. PubMed ID: 32155117
[TBL] [Abstract][Full Text] [Related]
7. A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8
Ma R; Ji T; Zhang H; Dong W; Chen X; Xu P; Chen D; Liang X; Yin X; Liu Y; Ma J; Tang K; Zhang Y; Peng Y; Lu J; Zhang Y; Qin X; Cao X; Wan Y; Huang B
Nat Cell Biol; 2018 Jan; 20(1):21-27. PubMed ID: 29230018
[TBL] [Abstract][Full Text] [Related]
8. miR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression.
Escobar TM; Kanellopoulou C; Kugler DG; Kilaru G; Nguyen CK; Nagarajan V; Bhairavabhotla RK; Northrup D; Zahr R; Burr P; Liu X; Zhao K; Sher A; Jankovic D; Zhu J; Muljo SA
Immunity; 2014 Jun; 40(6):865-79. PubMed ID: 24856900
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic control of CD8
Henning AN; Roychoudhuri R; Restifo NP
Nat Rev Immunol; 2018 May; 18(5):340-356. PubMed ID: 29379213
[TBL] [Abstract][Full Text] [Related]
10. Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8
Hermans D; Gautam S; García-Cañaveras JC; Gromer D; Mitra S; Spolski R; Li P; Christensen S; Nguyen R; Lin JX; Oh J; Du N; Veenbergen S; Fioravanti J; Ebina-Shibuya R; Bleck C; Neckers LM; Rabinowitz JD; Gattinoni L; Leonard WJ
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6047-6055. PubMed ID: 32123114
[TBL] [Abstract][Full Text] [Related]
11. NR4A transcription factors limit CAR T cell function in solid tumours.
Chen J; López-Moyado IF; Seo H; Lio CJ; Hempleman LJ; Sekiya T; Yoshimura A; Scott-Browne JP; Rao A
Nature; 2019 Mar; 567(7749):530-534. PubMed ID: 30814732
[TBL] [Abstract][Full Text] [Related]
12. Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo.
Dal-Pra S; Hodgkinson CP; Mirotsou M; Kirste I; Dzau VJ
Circ Res; 2017 Apr; 120(9):1403-1413. PubMed ID: 28209718
[TBL] [Abstract][Full Text] [Related]
13. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
[TBL] [Abstract][Full Text] [Related]
14. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Control of Epigenetics and Its Role in CD8
Yerinde C; Siegmund B; Glauben R; Weidinger C
Front Immunol; 2019; 10():2718. PubMed ID: 31849941
[TBL] [Abstract][Full Text] [Related]
16. EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins.
Gollavilli PN; Pawar A; Wilder-Romans K; Natesan R; Engelke CG; Dommeti VL; Krishnamurthy PM; Nallasivam A; Apel IJ; Xu T; Qin ZS; Feng FY; Asangani IA
Cancer Res; 2018 Aug; 78(16):4760-4773. PubMed ID: 29898995
[TBL] [Abstract][Full Text] [Related]
17. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells.
Klebanoff CA; Finkelstein SE; Surman DR; Lichtman MK; Gattinoni L; Theoret MR; Grewal N; Spiess PJ; Antony PA; Palmer DC; Tagaya Y; Rosenberg SA; Waldmann TA; Restifo NP
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1969-74. PubMed ID: 14762166
[TBL] [Abstract][Full Text] [Related]
18. miR-149-3p reverses CD8
Zhang M; Gao D; Shi Y; Wang Y; Joshi R; Yu Q; Liu D; Alotaibi F; Zhang Y; Wang H; Li Q; Zhang ZX; Koropatnick J; Min W
Open Biol; 2019 Oct; 9(10):190061. PubMed ID: 31594465
[TBL] [Abstract][Full Text] [Related]
19. STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice.
Wang Z; Celis E
Cancer Immunol Immunother; 2015 Aug; 64(8):1057-66. PubMed ID: 25986168
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
